Literature DB >> 10920730

Acute myocardial infarction in Canada: improvement with time.

A Dodek1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920730      PMCID: PMC1232550     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction.

Authors:  L Pilote; D P Miller; R M Califf; J S Rao; W D Weaver; E J Topol
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

2.  Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry).

Authors:  H V Anderson; R S Gibson; P H Stone; C P Cannon; F Aguirre; B Thompson; G L Knatterud; E Braunwald
Journal:  Am J Cardiol       Date:  1997-06-01       Impact factor: 2.778

3.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra; J C Hoorntje; M J de Boer; S Reiffers; K Miedema; J P Ottervanger; A W van 't Hof; H Suryapranata
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

Review 4.  Management of the postmyocardial infarction patient: a consensus report--revision of 1991 CCS guidelines.

Authors:  E L Fallen; J Cairns; W Dafoe; N Frasure-Smith; J Genest; D Massel; D Peretz; G J Tremblay; W L Williams
Journal:  Can J Cardiol       Date:  1995-06       Impact factor: 5.223

5.  Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.

Authors:  D B Mark; C D Naylor; M A Hlatky; R M Califf; E J Topol; C B Granger; J D Knight; C L Nelson; K L Lee; N E Clapp-Channing
Journal:  N Engl J Med       Date:  1994-10-27       Impact factor: 91.245

6.  Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).

Authors:  A Langer; M Fisher; R M Califf; S Goodman; C M O'Connor; R A Harrington; V Fuster
Journal:  Can J Cardiol       Date:  1999-10       Impact factor: 5.223

7.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

8.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

9.  Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization.

Authors:  J V Selby; B H Fireman; R J Lundstrom; B E Swain; A F Truman; C C Wong; E S Froelicher; H V Barron; M A Hlatky
Journal:  N Engl J Med       Date:  1996-12-19       Impact factor: 91.245

10.  Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.

Authors:  H V Barron; A D Michaels; C Maynard; N R Every
Journal:  J Am Coll Cardiol       Date:  1998-08       Impact factor: 24.094

View more
  2 in total

1.  Treating acute myocardial infarction.

Authors:  D Kollek
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Treating acute myocardial infarction.

Authors:  W D Panton
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.